Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including:
Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/screening-for-nash-in-patients-with-diabetes/slideset
See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics
Professor of Internal Medicine
Associate Chair for Clinical Trials
Saint Louis University School of Medicine
St Louis, Missouri
This program has been made available online.
Interactive video from Brent Tetri, MD, and CCO: impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease
Hear Philip Newsome, PhD FRCPE, discuss available approaches to managing NASH: lifestyle, vitamin E, compounds that target insulin resistance from CCO
Hear Philip Newsome, PhD FRCPE, discuss the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis from CCO
Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO